New this month on the Pharmaceutical News, we are going to be showcasing various pharmaceutical market country profiles, provided by Espicom Business Intelligence.

Espicom’s World Pharmaceutical Market reports…

…have already been utilized by senior management in trade and industry for more than three decades. Why? Simply because our experienced team of researchers and analysts integrate economic, scientific, demographic and language skills to create an unrivalled and critical appraisal of the operating environment for pharmaceutical companies.

Our professional team of experts continually access over 1,200 primary source information points in regulatory authorities, health organisations, statistics offices and industry. A great deal of the important information within Espicom’s Pharmaceutical Market reports is not readily available in English elsewhere. Espicom partners with the highly regarded Economist Intelligence Unit (EIU) to produce up-to-date economic data – a consistent requirement in these rapidly changing times.

By 2016, the world pharmaceutical market, such as pharmacy and hospital sales, is forecast to be worth around US$1.6 trillion at retail rates. High growth in emerging markets will leverage slow growth in created markets. Cost-containment policies will probably be offset against market place demands for much more useful merchandise. Health access will expand, because of escalating generic penetration.

This months featured pharmaceutical market profiles: